Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 13132Triple Negative Breast Neoplasms 1149Neoplasms 749Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 580Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 535Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 203Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Interventions

glembatumumab vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic gpNMB Expressing Triple Negative Breast Cancer × Breast × Clear all
NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

Celldex Therapeutics

No longer available
Breast

Metastatic gpNMB Expressing Triple Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡